Acceleron Pharma reported $787.85M in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acceleron Pharma XLRN:US $ 787.85M 48.2M
Akebia Therapeutics AKBA:US $ 602.27M 9.6M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Amgen AMGN:US $ 64993M 5220M
Arena Pharmaceuticals ARNA:US $ 901.03M 183.63M
Bayer BAYN:GR € 116549M 2122M
Biomarin Pharmaceutical BMRN:US $ 5977.48M 78.98M
Bluebird Bio BLUE:US $ 1339.64M 114.82M
Clovis Oncology CLVS:US $ 508M 64.23M
Dicerna Pharmaceuticals DRNA:US $ 772.06M 66.43M
Eli Lilly And LLY:US $ 48187M 378M
Exelixis EXEL:US $ 2447.74M 80.47M
Gilead Sciences GILD:US $ 67098M 886M
GlaxoSmithKline GSK:LN 78689M 1678M
Karyopharm Therapeutics KPTI:US $ 254.09M 32.47M
Mirati Therapeutics MRTX:US $ 1253.43M 102.27M
Neurocrine Biosciences NBIX:US $ 2017.3M 60.9M
Novartis NOVN:VX SF 121209M 2806M
Ptc Therapeutics PTCT:US $ 2007.32M 51.34M
Puma Biotechnology PBYI:US $ 226.29M 33.71M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M
Rigel Pharmaceuticals RIGL:US $ 186.52M 15.08M
Sangamo Biosciences SGMO:US $ 772.4M 62.96M
Tg Therapeutics TGTX:US $ 409.69M 71.71M
Ultragenyx Pharmaceutical RARE:US $ 1484.8M 27.64M
United Therapeutics UTHR:US $ 5048.9M 204M
Vertex Pharmaceuticals VRTX:US $ 12618.74M 397.06M